The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
affected more than 529 million people, and today the world is facing different mutant strains …

Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2) is a worldwide health
concern, and new treatment strategies are needed. Targeting inflammatory innate immunity …

The study of cytokine storm in COVID-19 has been having different edges in accordance
with the knowledge of the disease. Various cytokines have been the focus, especially to …

Systemic juvenile idiopathic arthritis (sJIA) is a serious multifactorial autoinflammatory
disease with a significant mortality rate due to macrophage activation syndrome (MAS) …

Critically ill COVID-19 patients with pleural effusion experience longer hospitalization,
multisystem inflammatory syndrome, and higher rates of mortality. Generally, pleural effusion …

The primary cause of mortality in patients of coronavirus disease 2019 (COVID-19) is the
cytokine storm and not directly due to the severe acute respiratory syndrome coronavirus 2 …

自新型冠状病毒肺炎(coronavirus disease 2019, COVID-19) 疫情暴发以来, 出现了若干COVID-
19 相关甲状腺疾病的报道, 包括亚急性甲状腺炎, 自身免疫性甲状腺疾病, 非甲状腺疾病综合征 …

Objectives: Retinal vascular complications have been described in patients with coronavirus
disease 2019 (COVID-19). This study aimed to analyze retinal microvascular changes and …

In late December 2019, in Wuhan, Hubei Province, China, a novel coronavirus, named
severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2), emerged. Most …